Every seminar one attends, carbon footprint reduction seems to be the primary topic of conversation in the print industry, with recyclables, chemicals and shifts to new, greener machinery seeming to dominate industry discussion. These are the big ticket items. I think, as a print CEO, one must also take a good hard look at building costs.
The counterfeit drug industry is estimated to be worth USD 200-bn a year and Asia appears to be its single largest producer. According to BASCAP (The Business Action to Stop Counterfeiting and Piracy), “Pharmaceutical industry is the most counterfeited industry in India”. Ankit Tanna, director of Printmann Group is determined to help pharma companies fight drug counterfeiting and save our economy from the venomous business.